Zoetis ZTS
NYSE ZTS
$73.28 -0.28 (-0.38%)
As of: Sep 9, 2026 · 3:48 PM EDT

Zoetis (ZTS) Capital Expenditures (2012 - 2026)

Zoetis' (ZTS) quarterly Capital Expenditures came in at $117.0 million in Q2 2026, down 19.86% year-over-year from $146.0 million in Q2 2025, and up 6.36% quarter-over-quarter from $110.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Capital Expenditures (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Capital Expenditures for 15 consecutive years, with $117.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Capital Expenditures fell 19.86% year-over-year to $117.0 million in Q2 2026; TTM through Jun 2026 was $524.0 million, a 25.88% decrease from a year earlier, with the FY2025 full-year figure at $621.0 million, down 5.19% from the prior year.
  • Capital Expenditures was $117.0 million for Q2 2026 at Zoetis, up from $110.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $223.0 million in Q1 2023 and troughed at $110.0 million in Q1 2026.
  • A 5-year average of $156.7 million and a median of $150.0 million in 2022 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures jumped 93.91% in 2023 and sank 38.2% in 2026, its largest moves.
  • Over 5 years, Capital Expenditures stood at $171.0 million in 2022, then increased by 15.79% to $198.0 million in 2023, then climbed by 9.09% to $216.0 million in 2024, then retreated by 25.46% to $161.0 million in 2025, then dropped by 27.33% to $117.0 million in 2026.
  • The last three Capital Expenditures figures came in at $117.0 million (Q2 2026), $110.0 million (Q1 2026), and $161.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Idexx Laboratories 40.60 Bn 40.40 Bn 779.09 Mn 24.65 Mn
2 Zoetis 30.59 Bn 28.91 Bn 1.05 Bn 117.00 Mn
3 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 33.00 Mn
4 Phibro Animal Health 1.50 Bn 1.42 Bn 134.40 Mn 18.87 Mn
5 Immucell 89.92 Mn 81.06 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 74.81 Mn 67.72 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - 55,116.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.00 Mn
Mar 31, 2026 110.00 Mn
Dec 31, 2025 161.00 Mn
Sep 30, 2025 136.00 Mn
Jun 30, 2025 146.00 Mn
Mar 31, 2025 178.00 Mn
Dec 31, 2024 216.00 Mn
Sep 30, 2024 167.00 Mn
Jun 30, 2024 132.00 Mn
Mar 31, 2024 140.00 Mn
Dec 31, 2023 198.00 Mn
Sep 30, 2023 145.00 Mn
Jun 30, 2023 166.00 Mn
Mar 31, 2023 223.00 Mn
Dec 31, 2022 171.00 Mn
Sep 30, 2022 154.00 Mn
Jun 30, 2022 146.00 Mn
Mar 31, 2022 115.00 Mn
Dec 31, 2021 168.00 Mn
Sep 30, 2021 119.00 Mn